Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)

China flag China · Delayed Price · Currency is CNY
56.82
-1.14 (-1.97%)
Sep 30, 2025, 3:00 PM CST
-1.97%
Market Cap35.05B
Revenue (ttm)1.24B
Net Income (ttm)765.39M
Shares Out616.79M
EPS (ttm)1.24
PE Ratio45.78
Forward PE114.40
Dividend0.12 (0.22%)
Ex-Dividend DateJun 13, 2025
Volume5,198,837
Average Volume7,134,514
Open58.21
Previous Close57.96
Day's Range56.20 - 58.21
52-Week Range19.82 - 68.68
Beta0.68
RSI56.22
Earnings DateOct 21, 2025

About SHA:688336

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs. Its products include YISAIPU, a tumor necrosis factor inhibitor type II-antibody fusion protein for the treatment of autoimmune rheumatism and immunology; Septin, an injection for anti-human epidermal growth factor receptor-2 treatment; and Jiannipa, a recombinant anti-CD25 humanized monoclonal antibody injection to prevent acute rejection caused by kidney transplantation. The company... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 995
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688336
Full Company Profile

Financial Performance

In 2024, SHA:688336's revenue was 1.19 billion, an increase of 17.70% compared to the previous year's 1.01 billion. Earnings were 704.58 million, an increase of 139.15%.

Financial Statements

News

There is no news available yet.